Tesamorelin Peptide

Tesamorelin, a synthetic Growth Hormone-Releasing Hormone peptide (GHRH), is used to treat HIV-associated lipodystrophy, a condition characterized by an accumulation of fat in the abdominal region as a side effect of HIV medicine. A condition known as HIV-associated lipodystrophy develops in people with HIV taking antiretroviral treatment.) Extensive clinical studies show Tesamorelin dramatically decreases abdomen fat with minimal adverse effects than HGH, but some abdominal fat may return after termination.